News Updates
Glaucoma and Ocular Surface Disease
Ocular surface disease is a debilitating condition that causes chronic ocular discomfort and impaired vision. It occurs at a higher rate in patients receiving treatment for glaucoma and undermines one of the primary treatment objectives in glaucoma management – to maximise quality of life.
Eye Associates is delighted to welcome Professor Jonathan Crowston
Eye Associates is delighted to welcome Professor Jonathan Crowston to our team of doctors.
Are 3 istents better than 2 for treating glaucoma?
Eye Associates is the national coordination centre for a new study into the benefit and safety of inserting 3 iStent inject trabecular bypass stents for lowering intraocular pressure.
Glaucoma Clinical Trial
Currently, the only treatment for glaucoma is to lower the eye pressure to reduce the stress on the optic nerve and hopefully slow down the rate of glaucoma damage. But what if we could directly stop the damage through medical therapy?
Eye Associates is delighted to welcome Dr Cheryl Au to our team.
Eye Associates is delighted to welcome Dr Cheryl Au to our team. Dr Au will be joining Prof Mark Gillies, Dr Adrian Hunt and Dr Anagha Vaze in providing our Medical Retina service.
